Literature DB >> 21112407

Rapid detection of ABC transporter interaction: potential utility in pharmacology.

Robert W Robey1, Bo Lin, Jean Qiu, Leo Li-Ying Chan, Susan E Bates.   

Abstract

INTRODUCTION: The ATP-binding cassette (ABC) transporters P-glycoprotein (P-gp/ABCB1), multidrug resistance-associated protein 1 (MRP1/ABCC1), and breast cancer resistance protein (BCRP/ABCG2) are known to transport a wide range of structurally diverse compounds. Their high level of expression at the blood-brain, maternal-fetal, and blood-testis barriers as well as their purported roles in oral absorption suggests that ABC transporters play important pharmacologic roles.
METHODS: We have developed a method to characterize the function and inhibition of ABC transporters using an automated cell counter with fluorescence detection capability. The assay was performed using stably-transfected HEK293 cells expressing P-gp, MRP1, or ABCG2 and examining transport of fluorescent substrates in the presence or absence of known inhibitors and compared to results obtained with a flow cytometer. Fold increase in intracellular fluorescence was then calculated for cells incubated with fluorescent substrate in the absence of inhibitor versus in the presence of inhibitor.
RESULTS: Fold increase values obtained either with the cell counter or flow cytometer were comparable for cells expressing either MRP1 or ABCG2; slightly higher fold increase values were observed when cells expressing P-gp were read on a flow cytometer compared to the cell counter. DISCUSSION: The assay described provides an inexpensive detection method to aid in the development of novel ABC transporter inhibitors or to characterize potential drug-drug interactions.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21112407      PMCID: PMC3086650          DOI: 10.1016/j.vascn.2010.11.003

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  25 in total

1.  Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.

Authors:  V V Rao; J L Dahlheimer; M E Bardgett; A Z Snyder; R A Finch; A C Sartorelli; D Piwnica-Worms
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 2.  Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.

Authors:  Ingolf Cascorbi
Journal:  Pharmacol Ther       Date:  2006-11       Impact factor: 12.310

Review 3.  ABCG2: determining its relevance in clinical drug resistance.

Authors:  Robert W Robey; Orsolya Polgar; John Deeken; Kin Wah To; Susan E Bates
Journal:  Cancer Metastasis Rev       Date:  2007-03       Impact factor: 9.264

4.  Brain accumulation of dasatinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by elacridar treatment.

Authors:  Jurjen S Lagas; Robert A B van Waterschoot; Vicky A C J van Tilburg; Michel J Hillebrand; Nienke Lankheet; Hilde Rosing; Jos H Beijnen; Alfred H Schinkel
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

5.  Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)).

Authors:  Robert W Robey; Suneet Shukla; Elizabeth M Finley; Robert K Oldham; Daryl Barnett; Suresh V Ambudkar; Tito Fojo; Susan E Bates
Journal:  Biochem Pharmacol       Date:  2007-12-14       Impact factor: 5.858

6.  In vivo evaluation of P-glycoprotein and breast cancer resistance protein modulation in the brain using [(11)C]gefitinib.

Authors:  Kazunori Kawamura; Tomoteru Yamasaki; Joji Yui; Akiko Hatori; Fujiko Konno; Katsushi Kumata; Toshiaki Irie; Toshimitsu Fukumura; Kazutoshi Suzuki; Iwao Kanno; Ming-Rong Zhang
Journal:  Nucl Med Biol       Date:  2009-04       Impact factor: 2.408

Review 7.  The blood-brain barrier and cancer: transporters, treatment, and Trojan horses.

Authors:  John F Deeken; Wolfgang Löscher
Journal:  Clin Cancer Res       Date:  2007-03-15       Impact factor: 12.531

8.  Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice.

Authors:  Serena Marchetti; Nienke A de Vries; Tessa Buckle; Maria J Bolijn; Maria A J van Eijndhoven; Jos H Beijnen; Roberto Mazzanti; Olaf van Tellingen; Jan H M Schellens
Journal:  Mol Cancer Ther       Date:  2008-08       Impact factor: 6.261

9.  A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients.

Authors:  Isa E L M Kuppens; Els O Witteveen; Roxanne C Jewell; Sandra A Radema; Elaine M Paul; Steve G Mangum; Jos H Beijnen; Emile E Voest; Jan H M Schellens
Journal:  Clin Cancer Res       Date:  2007-06-01       Impact factor: 12.531

Review 10.  Human multidrug transporter ABCG2, a target for sensitizing drug resistance in cancer chemotherapy.

Authors:  Junkang Xu; Hui Peng; Jian-Ting Zhang
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

View more
  18 in total

1.  A novel image-based cytometry method for autophagy detection in living cells.

Authors:  Leo Li-Ying Chan; Dee Shen; Alisha R Wilkinson; Wayne Patton; Ning Lai; Eric Chan; Dmitry Kuksin; Bo Lin; Jean Qiu
Journal:  Autophagy       Date:  2012-08-16       Impact factor: 16.016

2.  3D-QSAR AND CONTOUR MAP ANALYSIS OF TARIQUIDAR ANALOGUES AS MULTIDRUG RESISTANCE PROTEIN-1 (MRP1) INHIBITORS.

Authors:  Prathusha Kakarla; Madhuri Inupakutika; Amith R Devireddy; Shravan Kumar Gunda; Thomas Mark Willmon; K C Ranjana; Ugina Shrestha; Indrika Ranaweera; Alberto J Hernandez; Sharla Barr; Manuel F Varela
Journal:  Int J Pharm Sci Res       Date:  2016-02-01

3.  Collateral sensitivity of multidrug-resistant cells to the orphan drug tiopronin.

Authors:  Andrew S Goldsborough; Misty D Handley; Andrés E Dulcey; Kristen M Pluchino; Pavitra Kannan; Kyle R Brimacombe; Matthew D Hall; Gary Griffiths; Michael M Gottesman
Journal:  J Med Chem       Date:  2011-06-24       Impact factor: 7.446

4.  The Inhibitor Ko143 Is Not Specific for ABCG2.

Authors:  Lora D Weidner; Sami S Zoghbi; Shuiyu Lu; Suneet Shukla; Suresh V Ambudkar; Victor W Pike; Jan Mulder; Michael M Gottesman; Robert B Innis; Matthew D Hall
Journal:  J Pharmacol Exp Ther       Date:  2015-07-06       Impact factor: 4.030

5.  In Vitro Screening of Environmental Chemicals Identifies Zearalenone as a Novel Substrate of the Placental BCRP/ABCG2 Transporter.

Authors:  Jingcheng Xiao; Qi Wang; Kristin M Bircsak; Xia Wen; Lauren M Aleksunes
Journal:  Toxicol Res (Camb)       Date:  2015-05-01       Impact factor: 3.524

6.  Rapid image-based cytometry for comparison of fluorescent viability staining methods.

Authors:  Leo L Chan; Alisha R Wilkinson; Benjamin D Paradis; Ning Lai
Journal:  J Fluoresc       Date:  2012-06-21       Impact factor: 2.217

7.  A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.

Authors:  Tobie D Lee; Olivia W Lee; Kyle R Brimacombe; Lu Chen; Rajarshi Guha; Sabrina Lusvarghi; Bethilehem G Tebase; Carleen Klumpp-Thomas; Robert W Robey; Suresh V Ambudkar; Min Shen; Michael M Gottesman; Matthew D Hall
Journal:  Mol Pharmacol       Date:  2019-09-12       Impact factor: 4.436

8.  Assessment of drug transporter function using fluorescent cell imaging.

Authors:  Kristin M Bircsak; Christopher J Gibson; Robert W Robey; Lauren M Aleksunes
Journal:  Curr Protoc Toxicol       Date:  2013-09-23

9.  Discriminating multiplexed GFP reporters in primary articular chondrocyte cultures using image cytometry.

Authors:  Leo Li-Ying Chan; Jianping Huang; Yusuke Hagiwara; Leonardo Aguila; David Rowe
Journal:  J Fluoresc       Date:  2014-04-13       Impact factor: 2.217

10.  A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53(mut) exhibits ATP-binding cassette transporter upregulation and high glutathione levels.

Authors:  Manuel Tonigold; Annette Rossmann; Marie Meinold; Michael Bette; Melanie Märken; Katharina Henkenius; Anne C Bretz; Gavin Giel; Chengzhong Cai; Fiona R Rodepeter; Vladimir Beneš; Reidar Grénman; Thomas E Carey; Hermann Lage; Thorsten Stiewe; Andreas Neubauer; Jochen A Werner; Cornelia Brendel; Robert Mandic
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-10       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.